StockNews.com Begins Coverage on Arcadia Biosciences (NASDAQ:RKDA)

StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report issued on Sunday morning. The brokerage issued a sell rating on the basic materials company’s stock.

A number of other research firms also recently commented on RKDA. Lake Street Capital upgraded Arcadia Biosciences to a strong-buy rating in a report on Tuesday, May 14th. HC Wainwright cut their price objective on Arcadia Biosciences from $10.00 to $6.00 and set a buy rating on the stock in a research report on Thursday, May 23rd.

Arcadia Biosciences Price Performance

Shares of NASDAQ RKDA opened at $2.99 on Friday. The company has a market cap of $4.08 million, a PE ratio of -0.58 and a beta of 0.86. The company has a 50-day simple moving average of $2.96 and a 200-day simple moving average of $2.64. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $4.79.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.